Estrogen potentiates the behavioral and nucleus accumbens dopamine response to continuous haloperidol treatment in female rats

European Journal of Neuroscience

Volumn 39, Issue 2, 2014, Pages 257-265

  Madularu, Dan ^a   Shams, Waqqas M ^a   Brake, Wayne G ^a  

^a Dept of Electrical and Computer Engineering   (Canada)

Author keywords

Amphetamine; Antipsychotic; Estradiol; Microdialysis; Schizophrenia

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; ESTRADIOL; ESTROGEN; HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG CROSS REACTIVITY; DRUG POTENTIATION; DRUG RELEASE; ESTRUS CYCLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMPLANT; LOCOMOTION; LOW DRUG DOSE; MICRODIALYSIS; MINIPUMP; NONHUMAN; NUCLEUS ACCUMBENS; OVARIECTOMY; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

AMPHETAMINE; ANTIPSYCHOTIC; ESTRADIOL; MICRODIALYSIS; SCHIZOPHRENIA;

AMPHETAMINES; ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; ESTRADIOL; ESTROGENS; FEMALE; HALOPERIDOL; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84892669196     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12401     Document Type: Article

References (36)

1. Akhondzadeh, S., Nejatisafa, A.A., Amini, H., Mohammadi, M.R., Larijani, B., Kashani, L., Raisi, F. & Kamalipour, A. (2003) Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 1007-1012.
2. Almey, A., Filardo, E.J., Milner, T.A. & Brake, W.G. (2012) Estrogen receptors are found in glia and at extranuclear neuronal sites in the dorsal striatum of female rats: evidence for cholinergic but not dopaminergic colocalization. Endocrinology, 153, 5373-5383.
3. Angermeyer, M.C. & Kuhn, L. (1988) Gender differences in age at onset of schizophrenia. An overview. Eur. Arch. Psy. Clin. N., 237, 351-364.
4. Antelman, S.M., Kocan, D., Edwards, D.J., Knopf, S., Perel, J.M. & Stiller, R. (1986) Behavioral effects of a single neuroleptic treatment grow with the passage of time. Brain Res., 385, 58-67.
5. Castner, S.A., Vosler, P.S. & Goldman-Rakic, P.S. (2005) Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex. Biol. Psychiat., 57, 743-751.
6. Chavez, C., Hollaus, M., Scarr, E., Pavey, G., Gogos, A. & van den Buuse, M. (2010) The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain Res., 1321, 51-59.
7. Dipaolo, T., Falardeau, P. & Morissette, M. (1988) Striatal D-2 dopamine agonist binding-sites fluctuate during the rat estrous-cycle. Life Sci., 43, 665-672.
8. Featherstone, R.E., Kapur, S. & Fletcher, P.J. (2007) The amphetamine-induced sensitized state as a model of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 1556-1571.
9. Hafner, H. (2003) Gender differences in schizophrenia. Psychoneuroendocrino., 28(Suppl 2), 17-54.
10. Hafner, H., Behrens, S., De Vry, J. & Gattaz, W.F. (1991) An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiat. Res., 38, 125-134.
11. Hallonquist, J.D., Seeman, M.V., Lang, M. & Rector, N.A. (1993) Variation in symptom severity over the menstrual cycle of schizophrenics. Biol. Psychiat., 33, 207-209.
12. Hruska, R.E., Ludmer, L.M. & Silbergeld, E.K. (1980) Characterization of the striatal dopamine receptor supersensitivity produced by estrogen treatment of male rats. Neuropharmacology, 19, 923-926.
13. Hussain, D., Cossette, M. & Brake, W.G. (2013) Dorsal Striatal dopamine levels and memory system bias in ovariectomized rats with chronic low or phasic high estradiol replacement. Submitted.
14. Kapur, S., Zipursky, R., Jones, C., Remington, G. & Houle, S. (2000) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am. J. Psychiat., 157, 514-520.
15. Kulkarni, J., de Castella, A., Smith, D., Taffe, J., Keks, N. & Copolov, D. (1996) A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr. Res., 20, 247-252.
16. Kulkarni, J., Riedel, A., de Castella, A.R., Fitzgerald, P.B., Rolfe, T.J., Taffe, J. & Burger, H. (2001) Estrogen - a potential treatment for schizophrenia. Schizophr. Res., 48, 137-144.
17. Levesque, D. & Dipaolo, T. (1988) Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17-beta-Estradiol. Neurosci. Lett., 88, 113-118.
18. Levesque, D. & Dipaolo, T. (1989) Chronic Estradiol treatment increases ovariectomized rat striatal D-1 dopamine-receptors. Life Sci., 45, 1813-1820.
19. Melkersson, K.I., Hulting, A.L. & Rane, A.J. (2001) Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses. Brit. J. Clin. Pharmaco., 51, 317-324.
20. Overpeck, J.G., Colson, S.H., Hohmann, J.R., Applestine, M.S. & Reilly, J.F. (1978) Concentrations of circulating steroids in normal prepubertal and adult male and female humans, chimpanzees, rhesus monkeys, rats, mice, and hamsters: a literature survey. J. Toxicol. Env. Health Sci., 4, 785-803.
21. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates: Fourth Edition. Academic Press, San Diego, CA.
22. Peleg-Raibstein, D., Knuesel, I. & Feldon, J. (2008) Amphetamine sensitization in rats as an animal model of schizophrenia. Behav. Brain Res., 191, 190-201.
23. Quinlan, M.G., Hussain, D. & Brake, W.G. (2008) Use of cognitive strategies in rats: the role of estradiol and its interaction with dopamine. Horm. Behav., 53, 185-191.
24. Riecher-Rossler, A., Hafner, H., Stumbaum, M., Maurer, K. & Schmidt, R. (1994) Can estradiol modulate schizophrenic symptomatology? Schizophrenia Bull., 20, 203-214.
25. Robinson, T.E. (1984) Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology, 84, 466-475.
26. Robinson, T.E. & Becker, J.B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res., 396, 157-198.
27. Samaha, A.N., Seeman, P., Stewart, J., Rajabi, H. & Kapur, S. (2007) "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J. Neurosci., 27, 2979-2986.
28. Samaha, A.N., Reckless, G.E., Seeman, P., Diwan, M., Nobrega, J.N. & Kapur, S. (2008) Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery. Biol. Psychiat., 64, 145-152.
29. Seeman, P. (2006) Targeting the dopamine D2 receptor in schizophrenia. Expert Opin. Ther. Tar., 10, 515-531.
30. Seeman, P. (2009) Schizophrenia model of elevated D2(High) receptors: haloperidol reverses the amphetamine-induced elevation in dopamine D2(High). Schizophr. Res., 109, 191-192.
31. Seeman, P. (2010) Dopamine D2 receptors as treatment targets in schizophrenia. Clin. Schizophr. Relat. Psychoses, 4, 56-73.
32. Seeman, P. (2011) All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci. Ther., 17, 118-132.
33. Seeman, P. (2013) Are dopamine D2 receptors out of control in psychosis? Prog. Neuropsychopharmacol. Biol. Psychiatry, 46C, 146-152.
34. Sorge, R.E., Rajabi, H. & Stewart, J. (2005) Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement. Neuropsychopharmacol., 30, 1681-1692.
35. Stern, R.G., Kahn, R.S., Harvey, P.D., Amin, F., Apter, S.H. & Hirschowitz, J. (1993) Early response to haloperidol treatment in chronic schizophrenia. Schizophr. Res., 10, 165-171.
36. Tenn, C.C., Fletcher, P.J. & Kapur, S. (2003) Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr. Res., 64, 103-114.